Discuss This Drug

Amisulpride

CHEBI:CHEBI_64045

Definition

A member of the class of benzamides resulting from the formal condensation of the carboxy group of 4-amino-5-(ethylsulfonyl)-2-methoxybenzoic acid with the primary amino group of 2-(aminomethyl)-1-ethylpyrrolidine. It is a potent, selective dopamine D2 and D3 receptor antagonist. It is an atypical antipsychotic/antischizophrenic agent with limited extrapyrimidal side effects.

Chemical Information

Molecular Formula
C17H27N3O4S
Molecular Mass
369.47900
Charge
0
SMILES
CCN1CCCC1CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC
InChI
InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)
InChIKey
NTJOBXMMWNYJFB-UHFFFAOYSA-N

Alternative Names

  • 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide
  • 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide
  • 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide
  • Aminosultopride
  • amisulprida
  • amisulpride
  • amisulpridum

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:64045
DRON_00010000
46303
oboInOwl#hasDbXref
Wikipedia:Amisulpride

Additional References

Wikipedia:Amisulpride

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

core#notation
CHEBI:64045
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
46303
generic_name
AMISULPRIDE
oboInOwl#hasDbXref
Wikipedia:Amisulpride
oboInOwl#id
CHEBI:64045
rxcui
2467149
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
listing_expiration_date
20241231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
pharm_class_moa
Dopamine D2 Antagonists [MoA]
pharm_class
Dopamine-2 Receptor Antagonist [EPC]
pharm_class_epc
Dopamine-2 Receptor Antagonist [EPC]
marketing_start_date
20190529
package_marketing_start_date
29-MAY-19
active_ingredient_strength
2.5 mg/mL
labeler_name
Acacia Pharma Ltd
brand_name
Barhemsys
brand_name_base
Barhemsys
product_ndc
51604-1156
application_number
NDA209510
manufacturer_name
Acacia Pharma Ltd
spl_id
8a347d00-76b3-8e18-e053-2995a90a9184
active_ingredient_name
AMISULPRIDE
package_ndc
51604-1156-0
package_description
40 kg in 1 DRUM (51604-1156-0)
unii
8110R61I4U
spl_set_id
ab23bc6e-b6a8-165f-e053-2a95a90ab144
nui
N0000175799
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_35703
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_13602
owl#annotatedSource
t266391
owl#someValuesFrom
t3512170